Recently, cases of CNS tumors harboring EP300::BCOR(L1) fusions (21 reported cases) were described, sharing histopathological features with CNS tumors having BCOR ITD, but not the same methylation class [5, 17, 19]. This evidence concerns the gene BCOR and central nervous system neoplasm.